BiotechTube
Home/Proniras/Christopher Toombs, PhD, DABT
CT

Christopher Toombs, PhD, DABT

Cofounder & Chief Scientific Officer

Proniras

Therapeutic Areas

Substance Use DisordersCentral Nervous System (CNS) Disorders

Proniras Pipeline

DrugIndicationPhase
Tezampanel (PRN-001-01)Opioid Use Disorder (Opiate Withdrawal Syndrome)Phase 1

Leadership Team at Proniras

TQ
Thong Q. Le
President & CEO
LR
Lindsay Rayle
Vice President of Finance
AC
Andrew Chambers, MD
Addiction Psychiatry PI
View full Proniras profile